Table 2.
Characteristic | OS | RFS | ||||||
---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||
HR (95% CI) | P a | HR (95% CI) | P a | HR (95% CI) | P a | HR (95% CI) | P a | |
Gender(Male vs Female) | 1.037(0.556–1.934) | 0.908 | 1.205(0.615–2.358) | 0.587 | 1.228(0.733–2.059) | 0.435 | 1.343(0.782–2.307) | 0.284 |
Age,years (>55 vs ≤55) | 1.250(0.682–2.290) | 0.471 | 0.999(0.496–2.013) | 0.998 | 1.417(0.850–2.361) | 0.181 | 1.274(0.725–2.238) | 0.400 |
Tumor size,cm (>4 vs ≤4) | 7.791(3.447–17.607) | <0.001* | 4.596(1.600–13.198) | 0.005* | 7.472(3.773–14.797) | <0.001* | 5.666(2.517–12.755) | <0.001* |
T classification (T3 + T4 vs T1 + T2) | 11.583(5.912–22.693) | <0.001* | 0.753(0.167–3.394) | 0.711 | 5.185(3.067–8.766) | <0.001* | 0.337(0.094–1.209) | 0.095 |
N classification (N1 vs N0) | 2.099(0.646–6.818) | 0.217 | 1.075(0.289–4.006) | 0.914 | 1.904(0.688–2.267) | 0.215 | 1.328(0.438–4.028) | 0.616 |
TNM stage (III + IV vs I + II) | 10.006(5.261–19.028) | <0.001* | 9.571(2.034–45.026) | 0.004* | 5.157(3.025–8.793) | <0.001* | 9.613(2.456–37.623) | 0.001* |
Fuhrman grade (3 + 4 vs 1 + 2) | 1.742(0.916–3.316) | 0.091 | 3.779(1.645–8.680) | 0.002* | 2.628(1.568–4.405) | <0.001* | 4.978(2.669–9.282) | <0.001* |
Necrosis(Present vs Absent) | 2.493(1.153–5.392) | 0.020* | 4.808(1.649–14.017) | 0.004* | 1.905(0.936–3.876) | 0.076 | 3.734(1.548–9.004) | 0.003* |
FGL2 expression (High vs low) | 6.636(2.579–17.080) | <0.001* | 3.396(1.187–9.722) | 0.023* | 4.214(2.119–8.383) | <0.001* | 2.940(1.402–6.166) | 0.004* |
HR = hazard ratio; CI = confidence interval. a P-value from the Cox proportional hazards model; *Statistically significant (P < 0.05).